Multivariate analysis of clinical, operative and pathologic features of esophageal cancer: Who needs adjuvant therapy?

Diseases of the Esophagus

Volumn 15, Issue 2, 2002, Pages 155-159

  Zafirellis, K ^a   Dolan, K ^a,b   Fountoulakis, A ^a   Dexter, S P L ^a   Martin, I G ^a   Sue Ling, H M ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD VESSEL; CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; DATA BASE; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GASTRECTOMY; HUMAN; INFORMATION PROCESSING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PATIENT SELECTION; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 0036411672     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2002.00230.x     Document Type: Article

References (40)

1. Blot W J, Devesa S S. Kneller R W, Fraumeni J F. Rising incidence of adenocarcinoma of the oesophagus and gastric cardia. JAMA 1991; 265: 1287-1289.
2. Dolan K, Walker S J, Sutton R, Morris A I, Campbell F, Williams E M I. New classification of oesophageal and gastric carcinoma based derived from changing patterns in epidemiology. Br J Cancer 1999; 80: 834-842.
3. Faivre J, Forman D, Esteve J, Gatta G. Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE Working Group. Eur J Cancer 1998; 34: 2167-2175.
4. Farrow D C, Vaughan T L. Determinants of survival following the diagnosis of esophageal adenocarcinoma. Cancer Causes Control 1996; 7: 322-327.
5. Stipa S, Di Giorgio A, Ferri M. Surgical treatment of adenocarcinoma of the cardia. Surgery 1992; 111: 386-393.
6. Clark G W B, Roy M K, Corcoran B A, Carey P D. Carcinoma of the oesophagus: the time for a multidisciplinary approach. Surg Oncol 1996; 5: 149-164
7. O'Reilly S, Forastiere A. A new approach to oesophageal cancer. Br Med J 1994; 308: 1249-1250.
8. Siewert R J, Stein H J, Feith M, Bruecher B, Bartels B, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single institution of the Western world. Ann Surg 2001; 234: 360-369.
9. Muller J M. Erasmit T, Stelsner M, Zieren U, Pichlmaier H. Surgical therapy of Barrett's oesophageal cancer. Br J Surg 1990; 77: 845-857.
10. Arnott S J, Duncan W, Gignoux M et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 1998; 41: 579-583.
11. Kelsen D P, Ginsberg R, Pajak T F et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. New Engl J Med 1998; 339: 1979-1984.
12. Geh J I, Crellin A M, Glynne-Jones R. Preoperative chemoradiotherapy in oesophageal cancer. Br J Surg 2001; 88: 338-356.
13. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. New York: Wiley-Liss, 1997.
14. French University Association for Surgical Research. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991; 173: 123-130.
15. Ando N, Iizuka T, Kakegawa T et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the esophagus; the Japan Oncology Group Study. J Thorac Cardiovasc Surg 1997; 114: 203-204.
16. Bedard E L, Inculet R I, Malthaneer R A, Brecevic E, Vincent M, Dar R. The role of surgery and postoperative chemoradiation in patients with lymph node positive esophageal cancer. Cancer 2001; 91: 2423-2430.
17. Liberman M D,Shriver C D, Bleckner S, Burt M. Carcinoma of the esophagus. Prognostic significance of histologic type. J Thorac Cardiovasc Surg 1995; 109: 130-138.
18. Theunissen P H, Borchard F, Poortvliet D C. Histopathological evaluation of oesophageal carcinoma: the significance of venous invasion. Br J Surg 1991; 78: 930-932.
19. Dexter S P L, Sue-Ling H, McMahon M J, Quirke P, Mapstone N, Martin I G. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001; 48: 667-670.
20. Sugimachi K, Matsuoka H, Ohno S, Mori M, Kuwano H. Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma. Br J Surg 1988; 75: 1115-1118.
21. Tachibana M. Tabara H, Kotoh T et al. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. Am J Gastroenterol 1999; 94: 757-765.
22. Dresner S M, Lamb P J, Shenfine J, Haynes N, Griffin S M. Prognostic significance of perioperative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 2000; 264: 492-497.
23. Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
24. Cox D R. Regression models and life-tables. J R Stat Soc 1972; 34: 187-220.
25. Tachibana M, Kinugasa S, Dhar D K et al. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol 1999; 72: 88-93.
26. Bartels H, Stein H J, Siewert J R. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 1998; 85: 840-844.
27. Holscher A H, Bollschweiler E, Bumm R, Bartels H, Hofler H, Siewert J R. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995; 118: 845-855.
28. Siewert J R, Feith M, Werner M, Stein H J. Adenocarcinoma of the esophago-gastric junction: results of surgical therapy based on anatomical topographical classification in 1,002 patients. Ann Surg 2000; 232: 353-361.
29. Sagar P M, Johnston D, McMahon M J, Dixon M F, Quirke P. Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg 1993; 80: 1386-1388.
30. Lund O, Hasenkam J M, Aagaard M T, Kimose H H. Time related changes in characteristics of prognostic significance in carcinoma of the esophagus and cardia. Br J Surg 1989; 76: 1301-1307.
31. Doi N, Imada T, Aoyama N, Kameda Y, Koizumi H. Prognostic significance of the carcinoma area in the thickest part of the lymph node. Hepatogastroenterology 2000; 47: 728-732.
32. Korst R J, Rusch V W, Venkatraman E et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998; 115: 660-669.
33. Ellis F H, Heatley G J, Balogh K. Proposal for improved staging criteria for carcinoma of the esophagus and cardia. Eur J Cardiothorac Surg 1997; 12: 660-669.
34. Nishimaki T, Suzuki T, Suzuki S, Kuwabara S, Hatakeyama K. Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 1998; 186: 306-312.
35. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 364-372.
36. Roder J D, Busch R, Stein HJ, Fink U, Siewert J R. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994; 81: 410-413.
37. Tachibana M, Dhar D K, Kinugasa S et al. Esophageal cancer with distant lymph node metastases: prognostic significance of metastatic lymph node ratio. J Clin Gastroenterol J Clin Gastroenterol 2000; 31: 318-322.
38. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert H E. Incidence and prognostic significance of vascular and neural invasion in squamous cell carcinomas of the esophagus. Int J Cancer 1995; 61: 333-336.
39. Hirai T, Kuwahar M, Yoshida K, Osaki A, Toge T. The prognostic significance of p53, p21 (Waf1, Cip1), and cyclin D1 protein expression in esophageal cancer patients. Anticancer Res 1999; 19: 4587-4591.
40. Wang L S, Chow K C, Chi K H et al. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol 1999; 94: 1933-1940.